Suwon, South Korea

Hyun Ik Shin

This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 4 EPO patents. Top assignees: Yonsung Fine Chemical Co., Ltd., Yonsung Fine Chemical Co., Ltd., Ys Life Science Co. Ltd.. Active years: 2020-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyun Ik Shin. Retrieved from https://idiyas.com/inventor/hyun-ik-shin-israunpg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.8

ph-index = 1


Location History:

  • Yongin-si, KR (2020)
  • Suwon-si, KR (2020 - 2022)

Company Filing History:


Years Active: 2020-2026

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Hyun Ik Shin: Innovator in Ophthalmic Treatments

Introduction

Hyun Ik Shin is a notable inventor based in Suwon-si, South Korea. He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. With a total of 5 patents to his name, Shin's work reflects a commitment to advancing medical treatments.

Latest Patents

One of his latest patents is an ophthalmic composition for glaucoma treatment. This eye drop composition includes a prostaglandin analogue, a thickening agent, and a solubilizing agent, wherein the thickening agent is carboxymethylcellulose or a salt thereof, and the solubilizing agent is tyloxapol. Another significant patent is a method for preparing latanoprostene bunod and an intermediate therefor. This invention relates to a process that allows for the efficient and cost-effective preparation of latanoprostene bunod while minimizing side reactions.

Career Highlights

Throughout his career, Hyun Ik Shin has worked with various companies, including Yonsung Fine Chemical Co., Ltd. and Ys Life Science Co. Ltd. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Shin has collaborated with notable colleagues such as Kee Young Lee and Chang Young Oh. These partnerships have likely enhanced his research and development efforts in the field of ophthalmic treatments.

Conclusion

Hyun Ik Shin's contributions to glaucoma treatment through his innovative patents demonstrate his dedication to improving patient care. His work continues to influence the field of ophthalmology and showcases the importance of innovation in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…